

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 9.68459028 |
| 2 | epithelial cilium movement (GO:0003351) | 8.87057662 |
| 3 | axoneme assembly (GO:0035082) | 7.44877018 |
| 4 | left/right pattern formation (GO:0060972) | 6.05831156 |
| 5 | regulation of cilium movement (GO:0003352) | 5.96555522 |
| 6 | left/right axis specification (GO:0070986) | 5.12991537 |
| 7 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 5.06245893 |
| 8 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 4.93656262 |
| 9 | ventricular system development (GO:0021591) | 4.79052362 |
| 10 | plasma membrane repair (GO:0001778) | 4.77949999 |
| 11 | sarcomere organization (GO:0045214) | 4.77870516 |
| 12 | microtubule bundle formation (GO:0001578) | 4.77538931 |
| 13 | one-carbon compound transport (GO:0019755) | 4.55895015 |
| 14 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 4.48868242 |
| 15 | vitamin transmembrane transport (GO:0035461) | 4.39590362 |
| 16 | regulation of microtubule-based movement (GO:0060632) | 4.21846211 |
| 17 | cardiac myofibril assembly (GO:0055003) | 4.21044372 |
| 18 | diterpenoid biosynthetic process (GO:0016102) | 4.19201033 |
| 19 | sperm capacitation (GO:0048240) | 4.18728765 |
| 20 | primary alcohol catabolic process (GO:0034310) | 4.13052079 |
| 21 | ethanol metabolic process (GO:0006067) | 4.12833809 |
| 22 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 4.12469737 |
| 23 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 4.10883984 |
| 24 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 4.06693245 |
| 25 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 4.06097653 |
| 26 | actin-myosin filament sliding (GO:0033275) | 4.03782891 |
| 27 | muscle filament sliding (GO:0030049) | 4.03782891 |
| 28 | myofibril assembly (GO:0030239) | 4.00655895 |
| 29 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 3.89636982 |
| 30 | cilium organization (GO:0044782) | 3.86466362 |
| 31 | detection of calcium ion (GO:0005513) | 3.82266691 |
| 32 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.81640720 |
| 33 | regulation of skeletal muscle contraction (GO:0014819) | 3.80619294 |
| 34 | regulation of interleukin-5 production (GO:0032674) | 3.76428703 |
| 35 | cardiac muscle contraction (GO:0060048) | 3.75550735 |
| 36 | cilium assembly (GO:0042384) | 3.73769370 |
| 37 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.72939172 |
| 38 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 3.70993561 |
| 39 | regulation of membrane repolarization (GO:0060306) | 3.65217204 |
| 40 | * negative regulation of inclusion body assembly (GO:0090084) | 3.63481304 |
| 41 | intraciliary transport (GO:0042073) | 3.60688328 |
| 42 | regulation of germinal center formation (GO:0002634) | 3.53661697 |
| 43 | cytoplasmic microtubule organization (GO:0031122) | 3.49233975 |
| 44 | cell communication involved in cardiac conduction (GO:0086065) | 3.46301714 |
| 45 | gas transport (GO:0015669) | 3.42110075 |
| 46 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.40091734 |
| 47 | relaxation of cardiac muscle (GO:0055119) | 3.39096226 |
| 48 | regulation of interleukin-13 production (GO:0032656) | 3.37662285 |
| 49 | response to xenobiotic stimulus (GO:0009410) | 3.36574815 |
| 50 | centriole assembly (GO:0098534) | 3.36573599 |
| 51 | ventricular cardiac muscle cell action potential (GO:0086005) | 3.36434394 |
| 52 | actin-mediated cell contraction (GO:0070252) | 3.34881091 |
| 53 | regulation of cell communication by electrical coupling (GO:0010649) | 3.34425840 |
| 54 | cellular component assembly involved in morphogenesis (GO:0010927) | 3.32555524 |
| 55 | lung epithelium development (GO:0060428) | 3.30922818 |
| 56 | microtubule-based movement (GO:0007018) | 3.30563790 |
| 57 | regulation of actin filament-based movement (GO:1903115) | 3.28589482 |
| 58 | cell communication by electrical coupling (GO:0010644) | 3.27534191 |
| 59 | striated muscle contraction (GO:0006941) | 3.26890157 |
| 60 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.26670649 |
| 61 | negative regulation of B cell mediated immunity (GO:0002713) | 3.24750426 |
| 62 | negative regulation of immunoglobulin mediated immune response (GO:0002890) | 3.24750426 |
| 63 | potassium ion import (GO:0010107) | 3.22275910 |
| 64 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 3.20469399 |
| 65 | tolerance induction (GO:0002507) | 3.19706764 |
| 66 | tricarboxylic acid cycle (GO:0006099) | 3.16729541 |
| 67 | carnitine shuttle (GO:0006853) | 3.16138230 |
| 68 | ethanol oxidation (GO:0006069) | 3.15899139 |
| 69 | piRNA metabolic process (GO:0034587) | 3.15699954 |
| 70 | actomyosin structure organization (GO:0031032) | 3.15631991 |
| 71 | activation of protein kinase A activity (GO:0034199) | 3.11742825 |
| 72 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.11425482 |
| 73 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.11425482 |
| 74 | glomerular epithelial cell development (GO:0072310) | 3.06188414 |
| 75 | iron ion import (GO:0097286) | 3.05339593 |
| 76 | regulation of relaxation of muscle (GO:1901077) | 3.03677795 |
| 77 | negative regulation of potassium ion transport (GO:0043267) | 3.00872654 |
| 78 | histone H3-K9 demethylation (GO:0033169) | 2.98791350 |
| 79 | protein localization to cilium (GO:0061512) | 2.97453029 |
| 80 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.95669001 |
| 81 | positive regulation of cation channel activity (GO:2001259) | 2.94147389 |
| 82 | creatine metabolic process (GO:0006600) | 2.93962956 |
| 83 | heart trabecula formation (GO:0060347) | 2.93523909 |
| 84 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 2.92685136 |
| 85 | cell projection assembly (GO:0030031) | 2.89635668 |
| 86 | cardiac muscle cell development (GO:0055013) | 2.88698149 |
| 87 | male meiosis I (GO:0007141) | 2.87290760 |
| 88 | regulation of striated muscle contraction (GO:0006942) | 2.87191440 |
| 89 | skeletal muscle adaptation (GO:0043501) | 2.83485013 |
| 90 | carnitine transmembrane transport (GO:1902603) | 2.80922285 |
| 91 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 2.80815360 |
| 92 | regulation of response to osmotic stress (GO:0047484) | 2.79337263 |
| 93 | positive regulation of potassium ion transport (GO:0043268) | 2.79323433 |
| 94 | negative regulation of humoral immune response (GO:0002921) | 2.79051546 |
| 95 | sperm motility (GO:0030317) | 2.79026013 |
| 96 | protein targeting to Golgi (GO:0000042) | 2.76072066 |
| 97 | synapsis (GO:0007129) | 2.75540029 |
| 98 | cardiac conduction (GO:0061337) | 2.73933429 |
| 99 | regulation of ARF protein signal transduction (GO:0032012) | 2.73204317 |
| 100 | positive regulation of tolerance induction (GO:0002645) | 2.72430901 |
| 101 | macroautophagy (GO:0016236) | 2.71965892 |
| 102 | skeletal muscle contraction (GO:0003009) | 2.68494222 |
| 103 | membrane repolarization during action potential (GO:0086011) | 2.68002757 |
| 104 | membrane depolarization during action potential (GO:0086010) | 2.67856623 |
| 105 | amino-acid betaine transport (GO:0015838) | 2.66986381 |
| 106 | carnitine transport (GO:0015879) | 2.66986381 |
| 107 | cardiac cell development (GO:0055006) | 2.66861588 |
| 108 | fatty acid transmembrane transport (GO:1902001) | 2.66390780 |
| 109 | regulation of heart rate by cardiac conduction (GO:0086091) | 2.65302971 |
| 110 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.64913188 |
| 111 | cardiac muscle hypertrophy (GO:0003300) | 2.63054286 |
| 112 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 2.62288297 |
| 113 | microtubule polymerization or depolymerization (GO:0031109) | 2.62254818 |
| 114 | actin filament-based movement (GO:0030048) | 2.62230515 |
| 115 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 2.61357500 |
| 116 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 2.61227574 |
| 117 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.61151461 |
| 118 | DNA methylation involved in gamete generation (GO:0043046) | 2.60010516 |
| 119 | relaxation of muscle (GO:0090075) | 2.59661563 |
| 120 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.59376650 |
| 121 | striated muscle hypertrophy (GO:0014897) | 2.58438009 |
| 122 | sodium ion homeostasis (GO:0055078) | 2.57030863 |
| 123 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.56856260 |
| 124 | regulation of potassium ion transmembrane transport (GO:1901379) | 2.56688125 |
| 125 | cerebellar granule cell differentiation (GO:0021707) | 2.56316243 |
| 126 | cardiac muscle cell action potential (GO:0086001) | 2.55724691 |
| 127 | negative regulation of T cell differentiation in thymus (GO:0033085) | 2.55225011 |
| 128 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 2.55173217 |
| 129 | regulation of cation channel activity (GO:2001257) | 2.55145515 |
| 130 | membrane repolarization (GO:0086009) | 2.54594379 |
| 131 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 2.54447128 |
| 132 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 2.54447128 |
| 133 | apical protein localization (GO:0045176) | 2.54399783 |
| 134 | establishment of protein localization to Golgi (GO:0072600) | 2.53599661 |
| 135 | regulation of p38MAPK cascade (GO:1900744) | 2.53137824 |
| 136 | synaptic vesicle maturation (GO:0016188) | 2.53103346 |
| 137 | * regulation of inclusion body assembly (GO:0090083) | 2.52884112 |
| 138 | regulation of the force of heart contraction (GO:0002026) | 2.52078888 |
| 139 | sodium ion export (GO:0071436) | 2.51534088 |
| 140 | striated muscle atrophy (GO:0014891) | 2.51135965 |
| 141 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.49780956 |
| 142 | multicellular organismal water homeostasis (GO:0050891) | 2.49231666 |
| 143 | phosphatidylcholine biosynthetic process (GO:0006656) | 2.48596257 |
| 144 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 2.47706276 |
| 145 | muscle contraction (GO:0006936) | 2.47637269 |
| 146 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.46574329 |
| 147 | regulation of cardiac muscle cell contraction (GO:0086004) | 2.45919811 |
| 148 | cilium morphogenesis (GO:0060271) | 2.45705151 |
| 149 | regulation of cardiac muscle contraction (GO:0055117) | 2.45362178 |
| 150 | negative regulation of protein localization to cell surface (GO:2000009) | 2.43636893 |
| 151 | regulation of potassium ion transmembrane transporter activity (GO:1901016) | 2.43538433 |
| 152 | retinoic acid metabolic process (GO:0042573) | 2.42942264 |
| 153 | quaternary ammonium group transport (GO:0015697) | 2.42938048 |
| 154 | histone H3-K36 demethylation (GO:0070544) | 2.42487524 |
| 155 | potassium ion homeostasis (GO:0055075) | 2.42263789 |
| 156 | mitochondrion degradation (GO:0000422) | 2.40827059 |
| 157 | regulation of heart rate (GO:0002027) | 2.40650311 |
| 158 | cellular potassium ion homeostasis (GO:0030007) | 2.39211339 |
| 159 | regulation of synapse structural plasticity (GO:0051823) | 2.37957829 |
| 160 | oxygen transport (GO:0015671) | 2.37872211 |
| 161 | regulation of heart contraction (GO:0008016) | 2.36786081 |
| 162 | negative regulation of ion transmembrane transporter activity (GO:0032413) | 2.36623411 |
| 163 | adult heart development (GO:0007512) | 2.36475353 |
| 164 | positive regulation of ion transmembrane transporter activity (GO:0032414) | 2.35370253 |
| 165 | COPI coating of Golgi vesicle (GO:0048205) | 2.33581130 |
| 166 | Golgi transport vesicle coating (GO:0048200) | 2.33581130 |
| 167 | regulation of sodium ion transmembrane transport (GO:1902305) | 2.33236004 |
| 168 | cardiac muscle tissue morphogenesis (GO:0055008) | 2.32569506 |
| 169 | regulation of microtubule depolymerization (GO:0031114) | 2.30751863 |
| 170 | carnitine metabolic process (GO:0009437) | 2.29534448 |
| 171 | establishment of apical/basal cell polarity (GO:0035089) | 2.25833741 |
| 172 | axonemal dynein complex assembly (GO:0070286) | 15.0093263 |
| 173 | cilium or flagellum-dependent cell motility (GO:0001539) | 13.4005511 |
| 174 | cilium movement (GO:0003341) | 10.8851527 |
| 175 | motile cilium assembly (GO:0044458) | 10.8110168 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.21164342 |
| 2 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.64365000 |
| 3 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 2.25215304 |
| 4 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.96412749 |
| 5 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.90737270 |
| 6 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.85630628 |
| 7 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.80309813 |
| 8 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.76387802 |
| 9 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.76040468 |
| 10 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.75400163 |
| 11 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.75400163 |
| 12 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.75272258 |
| 13 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.74419449 |
| 14 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.69850968 |
| 15 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.69357477 |
| 16 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.66984691 |
| 17 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.64546966 |
| 18 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.56568852 |
| 19 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.55013531 |
| 20 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.53488217 |
| 21 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.53214342 |
| 22 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.49472003 |
| 23 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.47339904 |
| 24 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.41482322 |
| 25 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.40437189 |
| 26 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.39747173 |
| 27 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.39747173 |
| 28 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.38022542 |
| 29 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.38022280 |
| 30 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.37212648 |
| 31 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.36019121 |
| 32 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.33396573 |
| 33 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.31326579 |
| 34 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.29899757 |
| 35 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.29166743 |
| 36 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.26503524 |
| 37 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.26302700 |
| 38 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.25775991 |
| 39 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.24278198 |
| 40 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.23529012 |
| 41 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.22893206 |
| 42 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.21738345 |
| 43 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.21572976 |
| 44 | * JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.21145378 |
| 45 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.20519099 |
| 46 | KDM2B_26808549_Chip-Seq_K562_Human | 1.18772906 |
| 47 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.18178924 |
| 48 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.17887473 |
| 49 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.17453964 |
| 50 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.15640640 |
| 51 | GATA1_19941826_ChIP-Seq_K562_Human | 1.14534061 |
| 52 | GATA2_19941826_ChIP-Seq_K562_Human | 1.14151076 |
| 53 | TP63_23658742_ChIP-Seq_EP156T_Human | 1.13553786 |
| 54 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.13196671 |
| 55 | GATA1_22025678_ChIP-Seq_K562_Human | 1.12342563 |
| 56 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.11712959 |
| 57 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.11692088 |
| 58 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.11504475 |
| 59 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.10617401 |
| 60 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.08776441 |
| 61 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.06108257 |
| 62 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.05715513 |
| 63 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.05618113 |
| 64 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.05337322 |
| 65 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.04730541 |
| 66 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.04065793 |
| 67 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.03865069 |
| 68 | * SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.03554826 |
| 69 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 1.03399366 |
| 70 | * CTCF_27219007_Chip-Seq_Bcells_Human | 1.03126740 |
| 71 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.02577503 |
| 72 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 1.02245199 |
| 73 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.01853732 |
| 74 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.00156162 |
| 75 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.99119420 |
| 76 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.97701235 |
| 77 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.97664096 |
| 78 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.96948118 |
| 79 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.96034337 |
| 80 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.95492601 |
| 81 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.95472060 |
| 82 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.95360664 |
| 83 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.94660087 |
| 84 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.94243507 |
| 85 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.92304455 |
| 86 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.91281526 |
| 87 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.90997088 |
| 88 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.90925872 |
| 89 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.90820703 |
| 90 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.89691662 |
| 91 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.89578516 |
| 92 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.88935538 |
| 93 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.88744345 |
| 94 | ETV1_20927104_ChIP-Seq_GIST48_Human | 0.88516604 |
| 95 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.88381748 |
| 96 | P68_20966046_ChIP-Seq_HELA_Human | 0.88194936 |
| 97 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.88122802 |
| 98 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.88118450 |
| 99 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.87876490 |
| 100 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.87873837 |
| 101 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.87242625 |
| 102 | AR_19668381_ChIP-Seq_PC3_Human | 0.86822211 |
| 103 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.86671523 |
| 104 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.86612273 |
| 105 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.86412182 |
| 106 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.86294191 |
| 107 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.86184164 |
| 108 | TBL1_22424771_ChIP-Seq_293T_Human | 0.86091169 |
| 109 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.85779388 |
| 110 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.85456163 |
| 111 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.85366330 |
| 112 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.85119343 |
| 113 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.84642595 |
| 114 | STAT3_23295773_ChIP-Seq_U87_Human | 0.84271046 |
| 115 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 0.84159551 |
| 116 | VDR_22108803_ChIP-Seq_LS180_Human | 0.83259089 |
| 117 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.83012657 |
| 118 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.82987035 |
| 119 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.82855975 |
| 120 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.82829162 |
| 121 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.82412425 |
| 122 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.82387152 |
| 123 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 0.82254280 |
| 124 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.82236708 |
| 125 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.82165552 |
| 126 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.81969946 |
| 127 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.81964253 |
| 128 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.81902693 |
| 129 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.81778995 |
| 130 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.81752437 |
| 131 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.81646501 |
| 132 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.81423973 |
| 133 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.81382262 |
| 134 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.81352617 |
| 135 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.81196444 |
| 136 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.81151609 |
| 137 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.81071295 |
| 138 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.81032018 |
| 139 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.80412693 |
| 140 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.80175237 |
| 141 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.79964836 |
| 142 | PCGF4_22325352_ChIP-Seq_293T-Rex_Human | 0.79532196 |
| 143 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.79342327 |
| 144 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.78558634 |
| 145 | NFYB_21822215_ChIP-Seq_K562_Human | 0.78442082 |
| 146 | CBX2_22325352_ChIP-Seq_293T-Rex_Human | 0.77859470 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002837_dystrophic_cardiac_calcinosis | 5.51958897 |
| 2 | MP0000751_myopathy | 4.03282451 |
| 3 | MP0003646_muscle_fatigue | 3.77216167 |
| 4 | MP0004084_abnormal_cardiac_muscle | 3.68924282 |
| 5 | MP0002653_abnormal_ependyma_morphology | 3.66919034 |
| 6 | MP0004036_abnormal_muscle_relaxation | 3.47131836 |
| 7 | MP0008875_abnormal_xenobiotic_pharmacok | 3.36361311 |
| 8 | MP0000749_muscle_degeneration | 3.27423932 |
| 9 | MP0004215_abnormal_myocardial_fiber | 3.11735043 |
| 10 | MP0004145_abnormal_muscle_electrophysio | 3.11192933 |
| 11 | MP0002132_abnormal_respiratory_system | 2.98163591 |
| 12 | MP0002909_abnormal_adrenal_gland | 2.61645490 |
| 13 | MP0005330_cardiomyopathy | 2.44011746 |
| 14 | MP0004087_abnormal_muscle_fiber | 2.41351782 |
| 15 | MP0004130_abnormal_muscle_cell | 2.38776968 |
| 16 | MP0000013_abnormal_adipose_tissue | 2.33961656 |
| 17 | MP0005620_abnormal_muscle_contractility | 2.30083282 |
| 18 | MP0004043_abnormal_pH_regulation | 2.22809575 |
| 19 | MP0004859_abnormal_synaptic_plasticity | 2.21259682 |
| 20 | MP0000747_muscle_weakness | 2.17425173 |
| 21 | MP0002972_abnormal_cardiac_muscle | 2.17340024 |
| 22 | MP0004270_analgesia | 2.12379768 |
| 23 | MP0009780_abnormal_chondrocyte_physiolo | 2.05941613 |
| 24 | MP0002106_abnormal_muscle_physiology | 2.01538780 |
| 25 | MP0000383_abnormal_hair_follicle | 1.98366390 |
| 26 | MP0005083_abnormal_biliary_tract | 1.91280898 |
| 27 | MP0002277_abnormal_respiratory_mucosa | 1.91274828 |
| 28 | MP0005410_abnormal_fertilization | 1.90988303 |
| 29 | MP0004484_altered_response_of | 1.90411266 |
| 30 | MP0002269_muscular_atrophy | 1.89914861 |
| 31 | MP0003137_abnormal_impulse_conducting | 1.89615688 |
| 32 | MP0002877_abnormal_melanocyte_morpholog | 1.87483979 |
| 33 | MP0010678_abnormal_skin_adnexa | 1.79537119 |
| 34 | MP0002234_abnormal_pharynx_morphology | 1.78652281 |
| 35 | MP0004085_abnormal_heartbeat | 1.78117683 |
| 36 | MP0000759_abnormal_skeletal_muscle | 1.76521641 |
| 37 | MP0008775_abnormal_heart_ventricle | 1.74243995 |
| 38 | MP0008961_abnormal_basal_metabolism | 1.71524223 |
| 39 | MP0000750_abnormal_muscle_regeneration | 1.69052060 |
| 40 | MP0005369_muscle_phenotype | 1.68352308 |
| 41 | MP0010630_abnormal_cardiac_muscle | 1.54199615 |
| 42 | MP0001544_abnormal_cardiovascular_syste | 1.53751699 |
| 43 | MP0005385_cardiovascular_system_phenoty | 1.53751699 |
| 44 | MP0006138_congestive_heart_failure | 1.51870511 |
| 45 | MP0002160_abnormal_reproductive_system | 1.47807160 |
| 46 | MP0000678_abnormal_parathyroid_gland | 1.45463957 |
| 47 | MP0000003_abnormal_adipose_tissue | 1.44109675 |
| 48 | MP0004233_abnormal_muscle_weight | 1.42938220 |
| 49 | MP0003635_abnormal_synaptic_transmissio | 1.41818113 |
| 50 | MP0004510_myositis | 1.40321752 |
| 51 | MP0002822_catalepsy | 1.38111046 |
| 52 | MP0005666_abnormal_adipose_tissue | 1.33199250 |
| 53 | MP0005423_abnormal_somatic_nervous | 1.31901228 |
| 54 | MP0005375_adipose_tissue_phenotype | 1.29802097 |
| 55 | MP0005409_darkened_coat_color | 1.28725717 |
| 56 | MP0003698_abnormal_male_reproductive | 1.26644952 |
| 57 | MP0002168_other_aberrant_phenotype | 1.25032226 |
| 58 | MP0005670_abnormal_white_adipose | 1.21627705 |
| 59 | MP0001765_abnormal_ion_homeostasis | 1.21119257 |
| 60 | MP0001929_abnormal_gametogenesis | 1.20390387 |
| 61 | MP0003303_peritoneal_inflammation | 1.20356153 |
| 62 | MP0004185_abnormal_adipocyte_glucose | 1.19209666 |
| 63 | MP0003329_amyloid_beta_deposits | 1.17508326 |
| 64 | MP0005310_abnormal_salivary_gland | 1.16447578 |
| 65 | MP0005636_abnormal_mineral_homeostasis | 1.16257835 |
| 66 | MP0004019_abnormal_vitamin_homeostasis | 1.11893828 |
| 67 | MP0006036_abnormal_mitochondrial_physio | 1.10502265 |
| 68 | MP0004147_increased_porphyrin_level | 1.10467135 |
| 69 | MP0002735_abnormal_chemical_nociception | 1.10428776 |
| 70 | MP0002638_abnormal_pupillary_reflex | 1.10402315 |
| 71 | MP0002693_abnormal_pancreas_physiology | 1.09638046 |
| 72 | MP0005623_abnormal_meninges_morphology | 1.09167282 |
| 73 | MP0003878_abnormal_ear_physiology | 1.07143347 |
| 74 | MP0005377_hearing/vestibular/ear_phenot | 1.07143347 |
| 75 | MP0002078_abnormal_glucose_homeostasis | 1.04936405 |
| 76 | MP0008569_lethality_at_weaning | 1.03375581 |
| 77 | MP0003221_abnormal_cardiomyocyte_apopto | 1.01355751 |
| 78 | MP0005535_abnormal_body_temperature | 1.00388442 |
| 79 | MP0001346_abnormal_lacrimal_gland | 1.00210959 |
| 80 | MP0002272_abnormal_nervous_system | 0.99454834 |
| 81 | MP0003045_fibrosis | 0.99097665 |
| 82 | MP0003828_pulmonary_edema | 0.98668160 |
| 83 | MP0003283_abnormal_digestive_organ | 0.98128188 |
| 84 | MP0009745_abnormal_behavioral_response | 0.97392733 |
| 85 | MP0004133_heterotaxia | 0.97304962 |
| 86 | MP0005646_abnormal_pituitary_gland | 0.95885889 |
| 87 | MP0001664_abnormal_digestion | 0.95878888 |
| 88 | MP0010386_abnormal_urinary_bladder | 0.95344561 |
| 89 | MP0002249_abnormal_larynx_morphology | 0.95268329 |
| 90 | MP0002063_abnormal_learning/memory/cond | 0.95219506 |
| 91 | MP0008877_abnormal_DNA_methylation | 0.95215927 |
| 92 | MP0001944_abnormal_pancreas_morphology | 0.93415713 |
| 93 | MP0002064_seizures | 0.93104815 |
| 94 | MP0002734_abnormal_mechanical_nocicepti | 0.92338931 |
| 95 | MP0010234_abnormal_vibrissa_follicle | 0.91509771 |
| 96 | MP0000230_abnormal_systemic_arterial | 0.89665479 |
| 97 | MP0002067_abnormal_sensory_capabilities | 0.89615191 |
| 98 | MP0002108_abnormal_muscle_morphology | 0.89140517 |
| 99 | MP0004742_abnormal_vestibular_system | 0.88957684 |
| 100 | MP0003075_altered_response_to | 0.88809601 |
| 101 | MP0002229_neurodegeneration | 0.88606800 |
| 102 | MP0001299_abnormal_eye_distance/ | 0.87261899 |
| 103 | MP0005166_decreased_susceptibility_to | 0.85740013 |
| 104 | MP0003950_abnormal_plasma_membrane | 0.83646080 |
| 105 | MP0003453_abnormal_keratinocyte_physiol | 0.82831170 |
| 106 | MP0001501_abnormal_sleep_pattern | 0.82688713 |
| 107 | MP0000566_synostosis | 0.82259099 |
| 108 | MP0008789_abnormal_olfactory_epithelium | 0.78978612 |
| 109 | MP0002127_abnormal_cardiovascular_syste | 0.78648053 |
| 110 | MP0003633_abnormal_nervous_system | 0.78620806 |
| 111 | MP0001440_abnormal_grooming_behavior | 0.78568951 |
| 112 | MP0009046_muscle_twitch | 0.77305383 |
| 113 | MP0005165_increased_susceptibility_to | 0.76893956 |
| 114 | MP0005187_abnormal_penis_morphology | 0.75516563 |
| 115 | MP0002971_abnormal_brown_adipose | 0.75434311 |
| 116 | MP0004858_abnormal_nervous_system | 0.75276502 |
| 117 | MP0002332_abnormal_exercise_endurance | 0.74691461 |
| 118 | MP0010368_abnormal_lymphatic_system | 0.74349667 |
| 119 | MP0003880_abnormal_central_pattern | 0.73922931 |
| 120 | MP0005386_behavior/neurological_phenoty | 0.72614630 |
| 121 | MP0004924_abnormal_behavior | 0.72614630 |
| 122 | MP0003195_calcinosis | 0.71991496 |
| 123 | MP0003690_abnormal_glial_cell | 0.71586515 |
| 124 | MP0003656_abnormal_erythrocyte_physiolo | 0.71293354 |
| 125 | MP0004885_abnormal_endolymph | 0.68342191 |
| 126 | MP0002066_abnormal_motor_capabilities/c | 0.68195852 |
| 127 | MP0009278_abnormal_bone_marrow | 0.67331678 |
| 128 | MP0003300_gastrointestinal_ulcer | 0.65913744 |
| 129 | MP0002572_abnormal_emotion/affect_behav | 0.65876964 |
| 130 | MP0001984_abnormal_olfaction | 0.64255146 |
| 131 | MP0002896_abnormal_bone_mineralization | 0.62930840 |
| 132 | MP0001502_abnormal_circadian_rhythm | 0.62756727 |
| 133 | MP0000266_abnormal_heart_morphology | 0.62286780 |
| 134 | MP0001970_abnormal_pain_threshold | 0.61755387 |
| 135 | MP0005167_abnormal_blood-brain_barrier | 0.61461963 |
| 136 | MP0003879_abnormal_hair_cell | 0.60563573 |
| 137 | MP0002295_abnormal_pulmonary_circulatio | 0.59114630 |
| 138 | MP0001486_abnormal_startle_reflex | 0.59047952 |
| 139 | MP0006072_abnormal_retinal_apoptosis | 0.58561467 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Bronchiectasis (HP:0002110) | 6.50626993 |
| 2 | Nasal polyposis (HP:0100582) | 6.34431364 |
| 3 | Exercise-induced myalgia (HP:0003738) | 5.78388298 |
| 4 | Abnormality of the nasal mucosa (HP:0000433) | 5.40670288 |
| 5 | Sudden death (HP:0001699) | 5.34678271 |
| 6 | Calf muscle hypertrophy (HP:0008981) | 4.98978075 |
| 7 | Hyporeflexia of lower limbs (HP:0002600) | 4.90619624 |
| 8 | Muscle hypertrophy of the lower extremities (HP:0008968) | 4.78846789 |
| 9 | Exercise-induced muscle cramps (HP:0003710) | 4.78401860 |
| 10 | Muscle fiber splitting (HP:0003555) | 4.56957342 |
| 11 | Bundle branch block (HP:0011710) | 4.13319628 |
| 12 | Myoglobinuria (HP:0002913) | 4.10279514 |
| 13 | Ventricular tachycardia (HP:0004756) | 3.94990254 |
| 14 | Abnormality of the calf musculature (HP:0001430) | 3.93874105 |
| 15 | Infertility (HP:0000789) | 3.93836907 |
| 16 | Recurrent sinusitis (HP:0011108) | 3.82128064 |
| 17 | Difficulty running (HP:0009046) | 3.81967691 |
| 18 | Bronchitis (HP:0012387) | 3.70537494 |
| 19 | Atrial fibrillation (HP:0005110) | 3.66708575 |
| 20 | Prolonged QT interval (HP:0001657) | 3.63357309 |
| 21 | Muscle fiber inclusion bodies (HP:0100299) | 3.63170935 |
| 22 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.54432540 |
| 23 | Subaortic stenosis (HP:0001682) | 3.54432540 |
| 24 | EMG: myopathic abnormalities (HP:0003458) | 3.53512870 |
| 25 | Ventricular fibrillation (HP:0001663) | 3.51131440 |
| 26 | Male infertility (HP:0003251) | 3.50482714 |
| 27 | Primary atrial arrhythmia (HP:0001692) | 3.44507424 |
| 28 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 3.43661591 |
| 29 | Syncope (HP:0001279) | 3.39921024 |
| 30 | Recurrent otitis media (HP:0000403) | 3.32643235 |
| 31 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 3.32282692 |
| 32 | Chronic sinusitis (HP:0011109) | 3.32077108 |
| 33 | Asymmetric septal hypertrophy (HP:0001670) | 3.27064546 |
| 34 | Supraventricular tachycardia (HP:0004755) | 3.23236890 |
| 35 | Chronic bronchitis (HP:0004469) | 3.21671842 |
| 36 | Hyperinsulinemic hypoglycemia (HP:0000825) | 3.20171355 |
| 37 | Supraventricular arrhythmia (HP:0005115) | 3.17128210 |
| 38 | Type 1 muscle fiber predominance (HP:0003803) | 3.12322605 |
| 39 | Right ventricular cardiomyopathy (HP:0011663) | 3.11466096 |
| 40 | Heart block (HP:0012722) | 3.05411337 |
| 41 | Ketoacidosis (HP:0001993) | 3.01078569 |
| 42 | Hyperkalemia (HP:0002153) | 2.94901163 |
| 43 | Increased variability in muscle fiber diameter (HP:0003557) | 2.92894394 |
| 44 | Myotonia (HP:0002486) | 2.92538975 |
| 45 | Abnormal atrioventricular conduction (HP:0005150) | 2.92529194 |
| 46 | Hyperactive renin-angiotensin system (HP:0000841) | 2.90268785 |
| 47 | Nemaline bodies (HP:0003798) | 2.89728521 |
| 48 | Difficulty climbing stairs (HP:0003551) | 2.87153248 |
| 49 | Ventricular arrhythmia (HP:0004308) | 2.86879768 |
| 50 | Increased connective tissue (HP:0009025) | 2.85856113 |
| 51 | Atelectasis (HP:0100750) | 2.82909834 |
| 52 | Atrioventricular block (HP:0001678) | 2.82167195 |
| 53 | Lipoatrophy (HP:0100578) | 2.78039597 |
| 54 | Occipital encephalocele (HP:0002085) | 2.77832880 |
| 55 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.71501098 |
| 56 | Palpitations (HP:0001962) | 2.67687727 |
| 57 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.65464159 |
| 58 | Absent/shortened dynein arms (HP:0200106) | 2.65464159 |
| 59 | Dilated cardiomyopathy (HP:0001644) | 2.63504956 |
| 60 | Abnormal EKG (HP:0003115) | 2.62791061 |
| 61 | Large for gestational age (HP:0001520) | 2.61817847 |
| 62 | Chronic otitis media (HP:0000389) | 2.59030907 |
| 63 | Hypoglycemic coma (HP:0001325) | 2.58126473 |
| 64 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.58103536 |
| 65 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.53867308 |
| 66 | Hyperglycemia (HP:0003074) | 2.46062229 |
| 67 | Central scotoma (HP:0000603) | 2.45874137 |
| 68 | Muscle stiffness (HP:0003552) | 2.43554608 |
| 69 | Rhabdomyolysis (HP:0003201) | 2.38596474 |
| 70 | Myopathic facies (HP:0002058) | 2.38508251 |
| 71 | EMG: neuropathic changes (HP:0003445) | 2.38185791 |
| 72 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.31292396 |
| 73 | Distal arthrogryposis (HP:0005684) | 2.26927128 |
| 74 | Neck muscle weakness (HP:0000467) | 2.24090136 |
| 75 | Tubulointerstitial nephritis (HP:0001970) | 2.24028219 |
| 76 | Pheochromocytoma (HP:0002666) | 2.23116251 |
| 77 | True hermaphroditism (HP:0010459) | 2.20302738 |
| 78 | Pancreatic fibrosis (HP:0100732) | 2.19556840 |
| 79 | Decreased circulating renin level (HP:0003351) | 2.19429952 |
| 80 | Rhinitis (HP:0012384) | 2.18096419 |
| 81 | Round ear (HP:0100830) | 2.17611639 |
| 82 | Left ventricular hypertrophy (HP:0001712) | 2.17283095 |
| 83 | Bell-shaped thorax (HP:0001591) | 2.16410422 |
| 84 | Diaphragmatic weakness (HP:0009113) | 2.15559706 |
| 85 | Gowers sign (HP:0003391) | 2.14096628 |
| 86 | Testicular atrophy (HP:0000029) | 2.11259124 |
| 87 | Nephronophthisis (HP:0000090) | 2.09045771 |
| 88 | Abnormal ciliary motility (HP:0012262) | 2.08775329 |
| 89 | Fetal akinesia sequence (HP:0001989) | 2.06605382 |
| 90 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.06326810 |
| 91 | Rapidly progressive (HP:0003678) | 2.05867577 |
| 92 | Cystic liver disease (HP:0006706) | 2.03865388 |
| 93 | Areflexia of lower limbs (HP:0002522) | 2.03134971 |
| 94 | Visual hallucinations (HP:0002367) | 1.98644862 |
| 95 | Scapular winging (HP:0003691) | 1.95025505 |
| 96 | Hypoglycemic seizures (HP:0002173) | 1.94835467 |
| 97 | Ketosis (HP:0001946) | 1.93782375 |
| 98 | Dysmetric saccades (HP:0000641) | 1.93639401 |
| 99 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.93256724 |
| 100 | Foot dorsiflexor weakness (HP:0009027) | 1.91172018 |
| 101 | Limb-girdle muscle atrophy (HP:0003797) | 1.90244949 |
| 102 | Obstructive sleep apnea (HP:0002870) | 1.89628428 |
| 103 | Abnormality of the foot musculature (HP:0001436) | 1.87070566 |
| 104 | Facial diplegia (HP:0001349) | 1.86478932 |
| 105 | Proximal amyotrophy (HP:0007126) | 1.86419718 |
| 106 | Abnormality of potassium homeostasis (HP:0011042) | 1.85229882 |
| 107 | Abnormality of the neuromuscular junction (HP:0003398) | 1.81884608 |
| 108 | Fatigable weakness (HP:0003473) | 1.81884608 |
| 109 | Frequent falls (HP:0002359) | 1.81660268 |
| 110 | Neuroendocrine neoplasm (HP:0100634) | 1.80962558 |
| 111 | Muscular dystrophy (HP:0003560) | 1.77532159 |
| 112 | Hypokalemia (HP:0002900) | 1.75902624 |
| 113 | Recurrent bronchitis (HP:0002837) | 1.75500735 |
| 114 | Distal lower limb amyotrophy (HP:0008944) | 1.75125077 |
| 115 | Lower limb amyotrophy (HP:0007210) | 1.74109238 |
| 116 | Depression (HP:0000716) | 1.72984807 |
| 117 | Rimmed vacuoles (HP:0003805) | 1.72123125 |
| 118 | Abnormal respiratory epithelium morphology (HP:0012253) | 1.71087399 |
| 119 | Abnormal respiratory motile cilium morphology (HP:0005938) | 1.71087399 |
| 120 | Gout (HP:0001997) | 1.69015770 |
| 121 | Distal lower limb muscle weakness (HP:0009053) | 1.68814295 |
| 122 | Cholelithiasis (HP:0001081) | 1.68492893 |
| 123 | Renal salt wasting (HP:0000127) | 1.68207443 |
| 124 | Abnormality of the renal medulla (HP:0100957) | 1.67400236 |
| 125 | Atonic seizures (HP:0010819) | 1.66964044 |
| 126 | Molar tooth sign on MRI (HP:0002419) | 1.66578991 |
| 127 | Abnormality of midbrain morphology (HP:0002418) | 1.66578991 |
| 128 | Hypoplastic ischia (HP:0003175) | 1.65734169 |
| 129 | Abnormality of chloride homeostasis (HP:0011422) | 1.61452621 |
| 130 | Chronic hepatic failure (HP:0100626) | 1.58834609 |
| 131 | Nonprogressive disorder (HP:0003680) | 1.56293355 |
| 132 | Hyperaldosteronism (HP:0000859) | 1.55724046 |
| 133 | Ankle clonus (HP:0011448) | 1.54370376 |
| 134 | Hyponatremia (HP:0002902) | 1.53380947 |
| 135 | Postaxial foot polydactyly (HP:0001830) | 1.52944706 |
| 136 | Congenital hepatic fibrosis (HP:0002612) | 1.52139612 |
| 137 | Pancreatic cysts (HP:0001737) | 1.49061256 |
| 138 | Abnormality of renin-angiotensin system (HP:0000847) | 1.43200728 |
| 139 | Abnormality of the dental root (HP:0006486) | 1.40810706 |
| 140 | Taurodontia (HP:0000679) | 1.40810706 |
| 141 | Abnormality of permanent molar morphology (HP:0011071) | 1.40810706 |
| 142 | Postural instability (HP:0002172) | 1.40125060 |
| 143 | Tubular atrophy (HP:0000092) | 1.39764219 |
| 144 | Lip pit (HP:0100267) | 1.37779556 |
| 145 | Cone-rod dystrophy (HP:0000548) | 1.37153089 |
| 146 | Gait imbalance (HP:0002141) | 1.35578698 |
| 147 | Absent speech (HP:0001344) | 1.34756920 |
| 148 | Focal motor seizures (HP:0011153) | 1.32682744 |
| 149 | Dysdiadochokinesis (HP:0002075) | 1.30627007 |
| 150 | Abnormality of sodium homeostasis (HP:0010931) | 1.30276336 |
| 151 | Medial flaring of the eyebrow (HP:0010747) | 1.30237451 |
| 152 | Popliteal pterygium (HP:0009756) | 1.29673295 |
| 153 | Anencephaly (HP:0002323) | 1.28022566 |
| 154 | Hypokalemic alkalosis (HP:0001949) | 1.27849483 |
| 155 | Abnormality of the dental pulp (HP:0006479) | 1.27592517 |
| 156 | Abnormality of molar (HP:0011077) | 1.27340777 |
| 157 | Abnormality of molar morphology (HP:0011070) | 1.27340777 |
| 158 | Hand muscle atrophy (HP:0009130) | 1.26726430 |
| 159 | Febrile seizures (HP:0002373) | 1.26117406 |
| 160 | Male pseudohermaphroditism (HP:0000037) | 1.25326449 |
| 161 | Congenital primary aphakia (HP:0007707) | 1.22744357 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TTN | 3.40535011 |
| 2 | PDK4 | 3.38893596 |
| 3 | PDK3 | 3.38893596 |
| 4 | MST4 | 3.22670634 |
| 5 | OBSCN | 3.15005803 |
| 6 | EPHA2 | 2.93594461 |
| 7 | PHKG1 | 2.88599406 |
| 8 | PHKG2 | 2.88599406 |
| 9 | PRKD3 | 2.86467729 |
| 10 | LMTK2 | 2.56393992 |
| 11 | DMPK | 2.54863101 |
| 12 | TRIB3 | 2.51815100 |
| 13 | INSRR | 2.12434921 |
| 14 | MAPK15 | 2.07585364 |
| 15 | PDK2 | 2.06306299 |
| 16 | PINK1 | 2.03874304 |
| 17 | WNK4 | 1.93641237 |
| 18 | TSSK6 | 1.64865036 |
| 19 | MUSK | 1.53302053 |
| 20 | MAP3K2 | 1.50915863 |
| 21 | KSR2 | 1.39825431 |
| 22 | NTRK3 | 1.36860807 |
| 23 | TIE1 | 1.34562504 |
| 24 | RIPK4 | 1.34453474 |
| 25 | TRPM7 | 1.30936575 |
| 26 | PAK3 | 1.28195475 |
| 27 | STK39 | 1.26434105 |
| 28 | NEK6 | 1.25986523 |
| 29 | STK38 | 1.25310617 |
| 30 | EPHA4 | 1.24770626 |
| 31 | PKN2 | 1.23652269 |
| 32 | MAP3K1 | 1.23176658 |
| 33 | MAP3K9 | 1.23067329 |
| 34 | MYLK | 1.19226305 |
| 35 | EEF2K | 1.15281016 |
| 36 | MAPKAPK5 | 1.14940898 |
| 37 | MAP3K13 | 1.14920251 |
| 38 | WNK1 | 1.14771121 |
| 39 | PRKCH | 1.11910142 |
| 40 | MAP3K4 | 1.08967505 |
| 41 | CAMK1G | 1.08588339 |
| 42 | PRPF4B | 1.07438170 |
| 43 | MAP3K7 | 1.06846781 |
| 44 | TAOK1 | 1.06512101 |
| 45 | TAOK3 | 1.05556275 |
| 46 | PRKD1 | 1.02741483 |
| 47 | PAK6 | 1.01947273 |
| 48 | RIPK1 | 1.00205557 |
| 49 | HIPK2 | 0.97359305 |
| 50 | MAPKAPK3 | 0.96266893 |
| 51 | CAMK2D | 0.93151732 |
| 52 | DAPK2 | 0.91513144 |
| 53 | RET | 0.90924787 |
| 54 | PTK2B | 0.90161163 |
| 55 | PDPK1 | 0.89615055 |
| 56 | ICK | 0.89200584 |
| 57 | CDC42BPA | 0.88793372 |
| 58 | NTRK1 | 0.87904746 |
| 59 | EPHB1 | 0.86437060 |
| 60 | MAP2K4 | 0.86192711 |
| 61 | CDK19 | 0.85981604 |
| 62 | STK24 | 0.85736445 |
| 63 | FER | 0.85632416 |
| 64 | PDK1 | 0.83152015 |
| 65 | MET | 0.82700118 |
| 66 | PRKAA1 | 0.82278910 |
| 67 | SGK3 | 0.81165971 |
| 68 | PNCK | 0.79713134 |
| 69 | PDGFRA | 0.78718447 |
| 70 | MST1R | 0.77396322 |
| 71 | OXSR1 | 0.76781492 |
| 72 | CAMKK1 | 0.76399193 |
| 73 | STK11 | 0.72735588 |
| 74 | WEE1 | 0.71865778 |
| 75 | TBK1 | 0.68813068 |
| 76 | CAMK2A | 0.68697456 |
| 77 | NME1 | 0.68240187 |
| 78 | GRK5 | 0.68190339 |
| 79 | ROCK1 | 0.67158150 |
| 80 | CSK | 0.66844944 |
| 81 | UHMK1 | 0.66274759 |
| 82 | CDK5 | 0.65272563 |
| 83 | BCKDK | 0.65226364 |
| 84 | PIK3CG | 0.64895381 |
| 85 | SGK223 | 0.64307062 |
| 86 | SGK494 | 0.64307062 |
| 87 | PIK3CA | 0.64064209 |
| 88 | MARK2 | 0.63957142 |
| 89 | LATS1 | 0.63271820 |
| 90 | FGFR3 | 0.63198589 |
| 91 | NEK1 | 0.60459131 |
| 92 | MAP2K2 | 0.58932591 |
| 93 | PRKCI | 0.57206831 |
| 94 | MAP3K11 | 0.56924643 |
| 95 | TYRO3 | 0.56677296 |
| 96 | PRKD2 | 0.54626677 |
| 97 | EPHA3 | 0.54024037 |
| 98 | PTK6 | 0.53928908 |
| 99 | MAP2K3 | 0.53437658 |
| 100 | CAMK2G | 0.52315601 |
| 101 | NLK | 0.51929230 |
| 102 | RPS6KA2 | 0.51918364 |
| 103 | MAPK12 | 0.51817002 |
| 104 | MARK1 | 0.51099949 |
| 105 | PKN1 | 0.49089431 |
| 106 | SMG1 | 0.48152235 |
| 107 | MAP2K6 | 0.47567439 |
| 108 | MAPK10 | 0.47277671 |
| 109 | PRKCE | 0.47185214 |
| 110 | PRKAA2 | 0.46903484 |
| 111 | NEK9 | 0.46606724 |
| 112 | MAP3K3 | 0.46263188 |
| 113 | CAMK4 | 0.45617167 |
| 114 | SGK2 | 0.45504934 |
| 115 | DYRK1A | 0.45270791 |
| 116 | TESK1 | 0.45070430 |
| 117 | TAOK2 | 0.45026564 |
| 118 | MAP2K1 | 0.44542317 |
| 119 | SGK1 | 0.44403506 |
| 120 | MINK1 | 0.43617786 |
| 121 | CAMKK2 | 0.43531001 |
| 122 | DYRK1B | 0.43287705 |
| 123 | IRAK1 | 0.42977951 |
| 124 | CAMK1 | 0.41826058 |
| 125 | MAP3K12 | 0.41541117 |
| 126 | MAPK13 | 0.41194981 |
| 127 | MAPK7 | 0.38268464 |
| 128 | ERBB2 | 0.37976202 |
| 129 | STK38L | 0.37650613 |
| 130 | CAMK2B | 0.37185532 |
| 131 | RPS6KA3 | 0.37177338 |
| 132 | JAK1 | 0.37004471 |
| 133 | FRK | 0.36933825 |
| 134 | ARAF | 0.36302373 |
| 135 | PRKACA | 0.36124672 |
| 136 | LRRK2 | 0.35809964 |
| 137 | PRKACG | 0.35515198 |
| 138 | AKT2 | 0.35292382 |
| 139 | LATS2 | 0.34877066 |
| 140 | PRKG1 | 0.33407442 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 2.99819486 |
| 2 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.80927519 |
| 3 | Histidine metabolism_Homo sapiens_hsa00340 | 2.77179630 |
| 4 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.31004240 |
| 5 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 2.28906311 |
| 6 | Insulin secretion_Homo sapiens_hsa04911 | 2.25823091 |
| 7 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 2.24847855 |
| 8 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 2.03775171 |
| 9 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.88918057 |
| 10 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.88414828 |
| 11 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.87426360 |
| 12 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.68594044 |
| 13 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.68585267 |
| 14 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.67939653 |
| 15 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.63723128 |
| 16 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.63114304 |
| 17 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.62670148 |
| 18 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.57803352 |
| 19 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.56857230 |
| 20 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.56346168 |
| 21 | Circadian entrainment_Homo sapiens_hsa04713 | 1.55171425 |
| 22 | ABC transporters_Homo sapiens_hsa02010 | 1.54638794 |
| 23 | Olfactory transduction_Homo sapiens_hsa04740 | 1.52181556 |
| 24 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.46489099 |
| 25 | Renin secretion_Homo sapiens_hsa04924 | 1.45387514 |
| 26 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.44307181 |
| 27 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.43816583 |
| 28 | Long-term potentiation_Homo sapiens_hsa04720 | 1.41392286 |
| 29 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.37885289 |
| 30 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.30112671 |
| 31 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.28768123 |
| 32 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.28522953 |
| 33 | Salivary secretion_Homo sapiens_hsa04970 | 1.27748741 |
| 34 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.23521913 |
| 35 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.22835550 |
| 36 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.22707841 |
| 37 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.21770633 |
| 38 | Circadian rhythm_Homo sapiens_hsa04710 | 1.20410958 |
| 39 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 1.19825073 |
| 40 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.19049051 |
| 41 | Cocaine addiction_Homo sapiens_hsa05030 | 1.17914419 |
| 42 | GABAergic synapse_Homo sapiens_hsa04727 | 1.16860849 |
| 43 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.15903496 |
| 44 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.15584504 |
| 45 | Taste transduction_Homo sapiens_hsa04742 | 1.14686759 |
| 46 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.13730781 |
| 47 | Insulin resistance_Homo sapiens_hsa04931 | 1.13369336 |
| 48 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.12685120 |
| 49 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.11006714 |
| 50 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.10592330 |
| 51 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.10270957 |
| 52 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.10263397 |
| 53 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 1.07473077 |
| 54 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.06160135 |
| 55 | Morphine addiction_Homo sapiens_hsa05032 | 1.05297342 |
| 56 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.03118652 |
| 57 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.02951385 |
| 58 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.02497566 |
| 59 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.01193593 |
| 60 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.95838661 |
| 61 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.93560775 |
| 62 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.93097037 |
| 63 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.93032209 |
| 64 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.92036328 |
| 65 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.91576353 |
| 66 | Alzheimers disease_Homo sapiens_hsa05010 | 0.89729663 |
| 67 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.87981624 |
| 68 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.86859925 |
| 69 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.86770031 |
| 70 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.86129512 |
| 71 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.82257557 |
| 72 | Parkinsons disease_Homo sapiens_hsa05012 | 0.78519078 |
| 73 | Gap junction_Homo sapiens_hsa04540 | 0.77012892 |
| 74 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.76222497 |
| 75 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.76126754 |
| 76 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.75654677 |
| 77 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.75428720 |
| 78 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.72964680 |
| 79 | Carbon metabolism_Homo sapiens_hsa01200 | 0.71874163 |
| 80 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.70598260 |
| 81 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.69876585 |
| 82 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.69684672 |
| 83 | Tight junction_Homo sapiens_hsa04530 | 0.64400104 |
| 84 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.63383534 |
| 85 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.63297447 |
| 86 | Bile secretion_Homo sapiens_hsa04976 | 0.63065500 |
| 87 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.62946755 |
| 88 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.61462675 |
| 89 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.60837551 |
| 90 | Melanogenesis_Homo sapiens_hsa04916 | 0.60009409 |
| 91 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.59953542 |
| 92 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.59374295 |
| 93 | Focal adhesion_Homo sapiens_hsa04510 | 0.57289446 |
| 94 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.56675809 |
| 95 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.56199290 |
| 96 | Mineral absorption_Homo sapiens_hsa04978 | 0.55638323 |
| 97 | Long-term depression_Homo sapiens_hsa04730 | 0.55608628 |
| 98 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.55604153 |
| 99 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.55367573 |
| 100 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.54487696 |
| 101 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.53970335 |
| 102 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.53280008 |
| 103 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.52959506 |
| 104 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.52438948 |
| 105 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.52350761 |
| 106 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.51457581 |
| 107 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.51119584 |
| 108 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.50441548 |
| 109 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.50188225 |
| 110 | Nicotine addiction_Homo sapiens_hsa05033 | 0.49863998 |
| 111 | Hepatitis C_Homo sapiens_hsa05160 | 0.48293164 |
| 112 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.47530731 |
| 113 | Prion diseases_Homo sapiens_hsa05020 | 0.47154115 |
| 114 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.46689325 |
| 115 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.46643046 |
| 116 | Amoebiasis_Homo sapiens_hsa05146 | 0.46243686 |
| 117 | Glioma_Homo sapiens_hsa05214 | 0.45976170 |
| 118 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.45335035 |
| 119 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.43539560 |
| 120 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.42864180 |
| 121 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.42721217 |
| 122 | Huntingtons disease_Homo sapiens_hsa05016 | 0.42518528 |
| 123 | Retinol metabolism_Homo sapiens_hsa00830 | 0.42302301 |
| 124 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.41430825 |
| 125 | Endocytosis_Homo sapiens_hsa04144 | 0.41236579 |
| 126 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.41066435 |
| 127 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.37707406 |
| 128 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.36631275 |
| 129 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.35337063 |

